Wound-Healing Peptide Research Watchlist: What Is Better Supported?

Wound-healing peptide discussions are often dominated by two names: BPC-157 and TB-500. In practice, researchers also evaluate a broader set of candidates depending on tissue target, inflammation profile, antimicrobial needs, and handling constraints.

This page now uses a stricter evidence rule: peptides with directly verified wound-healing citations are separated from names that remain part of the broader discussion but still need stronger source review before they should be treated as well-supported leads.

10 Commonly Discussed Candidates

1. BPC-157
2. TB-500
3. GHK-Cu
4. Thymosin Alpha-1
5. LL-37
6. KPV
7. Ipamorelin
8. CJC-1295
9. Semax
10. Selank

Better-Supported Candidates in This Revision

Peptide	Primary Research Focus	Relative Stability	Evidence Confidence
BPC-157	Soft tissue, GI, repair signaling	Medium	Medium
GHK-Cu	Skin/repair signaling, remodeling	Medium	Medium
LL-37	Antimicrobial and immune modulation	Fragile	Medium
KPV	Anti-inflammatory signaling	Medium	Medium

Candidates Still Requiring Stronger Direct Citation Review

• TB-500 / Thymosin Beta-4 fragment
• Thymosin Alpha-1
• Ipamorelin
• CJC-1295
• Semax
• Selank

These names remain on the watchlist because they appear frequently in peptide-research discussions, but this article does not treat them as equivalently supported wound-healing leads without a finalized direct citation set.

BPC-157 vs TB-500: Practical Notes

• BPC-157 is commonly selected for localized or connective-tissue-centered workflows
• TB-500 is often discussed for broader systemic tissue-repair concepts, but this article now treats that discussion as lower-confidence until the direct citation set is finalized
• Both require disciplined handling, consistent tracking, and realistic confidence labeling

Handling Checklist for Research Quality

• Keep storage conditions consistent
• Track solvent type and reconstitution date
• Avoid overinterpreting early trend changes
• Review peptide-specific confidence levels before conclusions

Internal Links

• Compare compound profiles in Peptide Database
• Estimate potency trajectory in the Potency Calculator
• Track multiple vials in Multi-Vial Dashboard

---

Key References & Evidence

1. Sikiric P, et al. “Stable Gastric Pentadecapeptide BPC 157 and Wound Healing.” Front Pharmacol. 2021;12:627533. PMID 34267654 — Comprehensive BPC-157 wound healing review.

2. Chang CH, et al. “The promoting effect of pentadecapeptide BPC 157 on tendon healing involves tendon outgrowth, cell survival, and cell migration.” J Appl Physiol. 2011;110(3):774-80. PMID 21030672 — Tendon repair mechanism.

3. Sikiric P, et al. “Stable gastric pentadecapeptide BPC 157: novel therapy in gastrointestinal tract.” Curr Pharm Des. 2011;17(16):1612-32. PMID 21548867 — BPC-157 gastric stability and GI applications.

4. GHK-Cu wound healing: Pickart and Margolina — Regenerative and Protective Actions of the GHK-Cu Peptide in the Light of the New Gene Data (PMID 29986520); Wang et al. — GHK-Cu-liposomes accelerate scald wound healing in mice (PMID 28370978).

5. LL-37 wound healing: Miranda et al. — LL-37 cream in diabetic foot ulcer healing (PMID 37480520); Yang et al. — LL-37 hydrogel in mouse deep tissue injury healing (PMID 32321591).

6. KPV wound healing / repair context: Zhao et al. — KPV and EGF film improved diabetic wound repair in mice (PMID 36240893); Bonfiglio et al. — KPV effects on corneal epithelial wound healing (PMID 16965771); Bohm and Luger — review of melanocortin peptides in cutaneous wound healing (PMID 30661264).

7. TB-500 / Thymosin Beta-4: This revision does not treat TB-500 as source-validated for wound-healing ranking because a direct citation set was not finalized during review. It remains a watchlist item, not a verified evidence peer to BPC-157 in this article.

8. Stability classifications: ICH Q1A(R2) + ICH Q5C. Decay rates are [Model Estimates — PeptideClock].